SRTS Earnings Date & History
Sensus Healthcare Inc (NASDAQ NMS - GLOBAL MARKET) earnings schedule, consensus estimates and reported results for the last eight quarters.
Last updated Aug 19, 2026 at 7:17 PM ET
Sensus Healthcare Inc
Health Care
- Next earnings date
- Wednesday, November 4, 2026
- Reporting session
- After Close
- EPS estimate
- $-0.09
- Revenue estimate
- $6.4M
SRTS earnings history
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Thursday, August 13, 2026 | Q2 2026 | $-0.13 | $-0.18 | -41.2% | $2.3M |
| Thursday, May 7, 2026 | Q1 2026 | $-0.13 | $-0.16 | -25.5% | $3.4M |
| Thursday, February 12, 2026 | Q4 2025 | $-0.07 | $-0.19 | -166.1% | $4.9M |
| Thursday, November 6, 2025 | Q3 2025 | $-0.10 | $-0.06 | +38.1% | $6.9M |
| Thursday, August 7, 2025 | Q2 2025 | $0.03 | $-0.06 | -326.4% | $7.3M |
What the market is watching in SRTS's next report
- The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
- Ticker Read combines trend, relative strength and catalysts in one research view.
- Scanners, Impact Radar and the members-only Weekly Watchlist are included.
Get the week's earnings by email
One free email each week: the reports that matter, when they land, and what the market is watching.
Frequently asked questions
- When is the next SRTS earnings date?
- Sensus Healthcare Inc is scheduled to report on Wednesday, November 4, 2026 (After Close). Dates can change until the company confirms them.
- Does SRTS report before or after the market?
- The next report is scheduled after close.
- What EPS is expected for SRTS?
- Consensus EPS for the upcoming quarter is $-0.09, on revenue of $6.4M.
Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.
SRTS earnings discussion
Anyone can read. Any free Hyper Stocks account can join in.
Create a free account to join the discussion. Reading is open to everyone — commenting is free, no subscription needed.
Loading discussion…
Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.